Competition & Markets Authority
CMA opens investigation into NHS hospital trusts merger
The CMA yesterday started an investigation into the proposed merger between NHS hospital trusts in Poole and Bournemouth.
In 2013, the Competition and Markets Authority’s (CMA) predecessor, the Competition Commission, prohibited a previous merger between the Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust and Poole Hospital NHS Foundation Trust. As a result, the hospital trusts were required to enter into a 10-year commitment not to merge without the prior approval of the CMA.
Since the Competition Commission’s decision, there have been significant changes to policy within the NHS that have affected the role that competition plays. Competition between NHS hospitals is no longer used by the NHS to drive quality, with collaboration often viewed as a better way to meet increasing demands for care and deliver better value.
This has been taken into account in recent hospital mergers reviewed by the CMA, including the merger between Aintree University Hospital NHS Foundation Trust and The Royal Liverpool and Broadgreen University Hospitals NHS Trust, which was cleared in August 2019.
The CMA’s assessment of the potential effects of this merger on NHS services in the east Dorset area will take these policy changes into account. During the investigation, the CMA will work closely with Bournemouth and Poole Hospital trusts, the NHS regulators and local commissioners to assess the role that competition plays in how the hospitals provide services and whether any loss of competition brought about by the merger could have a negative impact on patients.
The CMA is also inviting views on these issues from patients and their representative groups, commissioning groups, other healthcare providers, regulators, local authorities and other interested bodies.
More broadly, the CMA is aware of longer-term NHS plans to exempt mergers between NHS hospitals from CMA review, which it fully supports.
For more information, visit the CMA’s dedicated webpage for the Royal Bournemouth and Christchurch Hospitals / Poole Hospital NHS Foundation Trusts merger investigation.
For media enquiries, contact the CMA press team on 020 3738 6460 or email@example.com.
Latest News from
Competition & Markets Authority
CMA breaks up motor parts merger13/01/2021 12:20:00
The CMA will require TVS Europe Distribution to sell 3G in order to protect competition in the commercial vehicle and trailer parts sector.
CMA to investigate Google’s ‘Privacy Sandbox’ browser changes08/01/2021 14:25:00
The CMA has opened an investigation into Google’s proposals to remove third party cookies and other functionalities from its Chrome browser.
CMA to investigate NVIDIA’s takeover of Arm07/01/2021 12:20:00
The CMA is inviting interested third parties to provide initial views on the anticipated acquisition of Arm by NVIDIA.
Metallurgy buyout raises competition concerns05/01/2021 09:10:00
The CMA has found that Tronox’s anticipated purchase of TTI raises competition concerns in the supply of chloride slag and titanium dioxide pigment.
CMA secures affordable supply of key bipolar drug21/12/2020 10:20:00
The CMA has accepted legally binding commitments from Essential Pharma to continue supplying a key bipolar drug at an affordable price for at least 5 years.
CMA publishes final report in funerals market investigation21/12/2020 09:20:00
The CMA has published the final report on its in-depth market investigation into funeral services, confirming its remedies for the sector.
Construction suppliers fined £15m for breaking competition law18/12/2020 12:20:00
The CMA has fined 2 major suppliers to the construction industry more than £15m for illegally colluding to reduce competition and keep prices up.
CMA publishes review of progress in legal services sector18/12/2020 08:28:00
The CMA’s assessment of changes in the legal services sector since its market study has found some positive developments but concludes more progress is needed.